Aminoterminal Pro B-Type Natriuretic Peptide (NT-proBNP) Levels for Monitoring Interventions in Paediatric Cardiac Patients with Stenotic Lesions. (24th January 2009)

• Record Type: Journal Article
• Authors: Welisch, Eva; Kleesiek, Knut; Haas, Nikolaus; Norozi, Kambiz; Rauch, Ralf; Filler, Guido
• Other Names: Oishi Peter Academic Editor.
• Is Part Of: International journal of pediatrics. Volume 2009(2009)
• Publication Date: 2009-01-24
• Subjects: Pediatrics -- Periodicals; 618.92
• DOI: 10.1155/2009/241376
• Languages: English
• ISSNs: 1687-9740

Abstract

Abstract : Background. Serum concentration of NT-proBNP correlates well with the severity of cardiac disease in adults. Few studies have been performed on the applicability of NT-proBNP for monitoring children with congenital heart disease. Objective. To assess the potential of NT-proBNP for monitoring the success of interventions in children with stenotic cardiac lesions. Methods. NT-proBNP was measured in 42 children aged 1 day to 17 years (y) before and 6 to 12 weeks after surgical or interventional correction of obstructive lesions of the heart. Comparison is made with the clinical status and echocardiographic data of the child. Results. NT-proBNP levels (median 280, range 10–263, 000 pg/mL) were above the reference value in all but 6 patients (pts) prior to the intervention. Higher levels were found in more compromised patients. The 35 children with clinical improvement after the procedure showed a decline of their NT-proBNP level in all but 4 patients, whose levels remained unchanged. Five patients with unchanged gradients despite a therapeutic intervention also demonstrated unchanged NT-proBNP levels after the intervention. Thus, the success rate of the procedure correlated well to clinical and echocardiographic findings. Conclusion. NT-proBNP can be used to assess the efficiency of an intervention.